Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals
Launched by PONCE MEDICAL SCHOOL FOUNDATION, INC. · Feb 24, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is designed to help medical students improve their understanding and skills in promoting cervical cancer screening for Latinx transmasculine and non-binary individuals. The researchers will provide specific training and resources to these students in Puerto Rico and Florida, aiming to see if this intervention helps them become more knowledgeable and supportive in offering gender-affirming healthcare. By comparing the students who receive this training with those who do not, the team hopes to find out if the intervention leads to better attitudes and behaviors regarding cervical cancer prevention.
To participate in this trial, you need to be a third-year medical student who is currently studying, and you should be able to speak English. The trial is not yet recruiting participants, but when it does, those who join can expect to be part of training sessions and discussions that focus on how to provide respectful and effective care to the Latinx transmasculine community. This study is important because it seeks to improve health outcomes for a group that often faces barriers to receiving appropriate medical care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Medical student currently in third year of medical school training
- Exclusion Criteria:
- • Do not speak English
About Ponce Medical School Foundation, Inc.
Ponce Medical School Foundation, Inc. is a dedicated research organization committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a focus on enhancing the educational and research capabilities of its affiliated institutions, the foundation fosters collaborations among healthcare professionals, researchers, and industry partners. By prioritizing ethical standards and patient safety, Ponce Medical School Foundation, Inc. aims to contribute to the development of cutting-edge therapies and interventions that address unmet medical needs, ultimately benefiting the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Alixida Ramos Pibernus, PhD
Principal Investigator
Ponce Health Sciences University
Matthew B Schabath, PhD
Principal Investigator
H. Lee Moffit Cancer Center and Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported